Mubadala Bio’s subsidiary secures prestigious EU Quality certification

UAE — Mubadala Bio, a life sciences company focused on improving health outcomes across the UAE and beyond, has announced a significant milestone for its subsidiary, Bioventure Healthcare.

The company successfully obtained European Union Good Manufacturing Practice (EU GMP) certification following comprehensive on-site inspections.

This achievement places Bioventure Healthcare among a select group of UAE-based manufacturers holding this prestigious certification.

The designation serves as a critical gateway for exporting pharmaceutical products to European Union markets, where stringent quality standards govern market access.

EU GMP certification confirms that Bioventure Healthcare meets the European Union’s demanding requirements for pharmaceutical manufacturing.

The standards ensure that medicines produced at the facility are safe, effective, and consistently manufactured to the highest specifications.

Dr. Essam Mohamed, CEO of Mubadala Bio, emphasized that the certification demonstrates Bioventure Healthcare’s capacity to deliver advanced, high-quality pharmaceutical products.

He noted that this accomplishment reflects the company’s broader commitment to strengthening healthcare resilience and developing local expertise within the sector.

Hamad Al Marzooqi, Deputy CEO of Mubadala Bio, highlighted how the certification aligns with the company’s mission to deliver better health outcomes.

He explained that this milestone strengthens their position as a trusted partner in the life sciences industry while enabling global expansion and building international confidence in their products.

State-of-the-Art Manufacturing Capabilities

Bioventure Healthcare operates the region’s largest soft gel capsule manufacturing facility for pharmaceutical products.

The 23,000 square-meter plant produces 1.5 billion capsules annually, utilizing cutting-edge technology throughout its operations.

The facility features advanced blister and bottle packaging lines, no-fill detection systems, and serialization capabilities with track-and-trace functionality.

A comprehensive quality control and microbiology laboratory ensures rigorous testing and compliance at every production stage.

These sophisticated systems enable Bioventure Healthcare to meet growing regional demand for high-quality pharmaceutical and supplement products while maintaining the safety and reliability standards required for international markets.

The EU GMP certification represents a pivotal step in Mubadala Bio’s long-term strategy to establish itself as a leader in global pharmaceutical manufacturing and distribution.

The company aims to support the UAE’s ambition of building a world-class pharmaceutical industry that delivers innovative health solutions while meeting internationally recognized quality benchmarks.